GOLDMAN SACHS GROUP INC - NEON THERAPEUTICS INC ownership

NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 45 filers reported holding NEON THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of NEON THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$36,000
-47.1%
13,771
-76.2%
0.00%
Q4 2019$68,000
-12.8%
57,814
+27.3%
0.00%
Q3 2019$78,000
-68.2%
45,418
-12.2%
0.00%
Q2 2019$245,000
+25.0%
51,750
+70.4%
0.00%
Q1 2019$196,000
+151.3%
30,377
+94.9%
0.00%
Q4 2018$78,000
-90.1%
15,587
-75.1%
0.00%
Q2 2018$788,00062,5000.00%
Other shareholders

There were no reported owners of NEON THERAPEUTICS INC in Q4 2018.

NameSharesValueWeighting ↓
View complete list of NEON THERAPEUTICS INC shareholders